Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Investigational New Drugs|March 4, 2005
Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trialTa-Chung Chao, Zyting Chu, Ling-Ming Tseng, et al.
Hematological Oncology|October 28, 2022
Prognostic factors in patients with bone marrow hemophagocytosis and its association with hematologic malignanciesJing-Gu Jiang, Chia-Jen Liu, Chiu-Mei Yeh, et al.
Oncology Reports|February 12, 2005
Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphomaMuh-Hwa Yang, Chueh-Chuan Yen, Shu-Chung Chiang, et al.
Cancer Medicine|January 17, 2023
Long-term outcomes of frontline intensification in primary CNS lymphoma: A real-world single-center experienceHao-Yuan Wang, Ching-Fen Yang, Chia-Hsin Lin, et al.
European Journal of Haematology|October 7, 2011
Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myelomaLiang-Tsai Hsiao, Ching-Fen Yang, Sheng-Hsiang Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipientsLiang-Tsai Hsiao, Tzeon-Jye Chiou, Jin-Hwang Liu, et al.
Hepato-Gastroenterology|March 12, 2004
EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancerWei-Shu Wang, Jen-Kou Lin, Tzu-Chen Lin, et al.
Hepato-Gastroenterology|April 11, 2002
CA19-9 as the most significant prognostic indicator of metastatic colorectal cancerWei-Shu Wang, Jen-Kou Lin, Tzeon-Jye Chiou, et al.
Hepato-Gastroenterology|May 9, 2002
Tumor marker CEA in monitoring of response to tegafur-uracil and folinic acid in patients with metastatic colorectal cancerWei-Shu Wang, Jen-Kou Lin, Tzu-Chen Lin, et al.
Blood Cells, Molecules & Diseases|May 16, 2015
No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutationJyh-Pyng Gau, Chih-Cheng Chen, Yi-Sheng Chou, et al.
Pageof 19